Long-term results of autologous marrow transplantation for relapsed or refractory male or female germ cell tumors

Bone Marrow Transplantation
R A MandanasG B Selby

Abstract

Twenty-one patients with relapsed or refractory germ cell tumors were treated with high-dose chemotherapy and marrow transplantation (HDC/BMT) from 1982-1993. Primary sites of disease were testis (17), ovary (three), and pineal gland (one). Pathology included dysgerminoma (one), choriocarcinoma with adenocarcinoma (one), seminoma (four), and nonseminoma or mixed germ cell tumor (15). Nineteen had at least two prior chemotherapy regimens and eight had cisplatin-refractory disease defined as progression within 4 weeks of a cycle of cisplatin-based chemotherapy. HDC regimens were mostly combinations of cyclophosphamide with etoposide and cisplatin or carboplatin. There were only two treatment-related deaths (aspergillosis and interstitial pneumonitis). Times to engraftment of granulocytes (21+/-8.3 days) and platelets (32+/-20.2 days) were reasonable with only the last nine patients receiving growth factors. At a minimum of 4 years follow-up, eight patients have died of disease, six of whom were cisplatin-refractory prior to transplant. Eleven patients (52% overall) are alive and continuously free of disease after 4-10 years including one of three with refractory ovarian germ cell tumor. HDC/BMT provides significant long-term dise...Continue Reading

Citations

Oct 26, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M R VeldwijkS Fruehauf
May 18, 1999·Current Opinion in Oncology·R T Oliver
Jul 31, 2003·Drugs·Uzair B Chaudhary, Jason R Haldas
Mar 1, 2011·Gynecologic Oncology·C A ParkinsonT V Ajithkumar
Jul 20, 2002·The Journal of Urology·Liann N HandelMartin A Koyle
Feb 13, 2003·Pediatric Clinics of North America·Ulrike Reiss, Ellen Bolotin
Oct 21, 2016·Pediatric Blood & Cancer·Ashley S PlantLindsay Frazier
Dec 17, 2002·Oncogene·Barbara Sedgwick, Tomas Lindahl
Oct 19, 2001·Oncogene·A Y TsygankovG Swaminathan
Aug 15, 2008·American Journal of Physiology. Cell Physiology·Zoe M GoeckelerRobert B Wysolmerski
Mar 5, 2020·Indian Journal of Cancer·Asawari AmbekarSantosh Menon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.